PREDICTING CANCER PROGRESSION

Title:

PREDICTING CANCER PROGRESSION

Document Type and Number:

WIPO Patent Application WO2004100760

Kind Code:

A8

Abstract:

The present invention involves early prediction of progression of a cancer disease in patients treated for cancer. According to the invention the binding response level of an immunoreactive material (IM) comprising thymidine kinase 1 (TK1) protein is determined in a body fluid sample of a patient and the likelihood of progress of the cancer disease is estimated based directly on this determined IM binding response level. Those patients that run a risk of cancer progress and tumor relapse 1-15 years after the cancer treatment may be identified directly by the IM binding response level according to the invention within a few months following initiation of the treatment.

More Like This:

JP2018154579	FUSION PROTEIN OF ANTIBODY FRAGMENT AND GLUCOSE DEHYDROGENASE
WO/2002/090524	ISOLATED NUCLEIC ACID MOLECULES ENCODING A NOVEL HUMAN SIGNAL TRANSDUCING KINASE-MAPKAP-2; ENCODED PROTEINS, CELLS TRANSFORMED THEREWITH AND USES THEREOF
WO/2007/142223	METHOD FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA

Inventors:

SKOG SVEN (SE)
ERIKSSON STAFFAN (SE)
TRIBUKAIT BERNHARD (SE)
HE QIMIN (SE)

Application Number:

PCT/SE2004/000750

Publication Date:

February 03, 2005

Filing Date:

May 14, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

XI BAO RES AB (SE)
SKOG SVEN (SE)
ERIKSSON STAFFAN (SE)
TRIBUKAIT BERNHARD (SE)
HE QIMIN (SE)

International Classes:

G01N33/573; G01N33/574; A61B; (IPC1-7): G01N33/573

Download PDF:

View/Download PDF PDF Help

Previous Patent: ENDO 180 RECEPTOR FOR DIAGNOSIS AND TREATMENT

Next Patent: SYSTEM AND METHOD FOR THERAPY AND DIAGNOSIS COMPRISING IN COMBINATION NON-MECHANICAL AND MECHANICAL ...